FDA
approval
· 2023-02-03
FDA Approved: BREXPIPRAZOLE — Original Application (Ajanta Pharma USA Inc.)
Summary
FDA approved Ajanta Pharma USA Inc.'s original application for brexpiprazole (brexpiprazole), authorizing a generic version of the antipsychotic.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BREXPIPRAZOLE (BREXPIPRAZOLE)